RE:Fireside chats What's the future line from Dano going to be?
the latest was - watch the s/p in the summer, with getting ready for the ph3 uplist/Nasdq simultaneity. Now it's, canidians don't do anything in the summer, let's wait to fall.
IMO- covid 19 is not a reason for a delay any longer. Here in the states we are back to capacity and moving as if it wasn't here.
I don't understand the harm in being transparent with the trial and dates? What, we miss the mark and the stock tanks? Lol, I mean, for such a great company with 55k pages of literature, and research, we sure love kicking it around the 52 year lows.
my problem is this-when management sells shares and grants theirselves more shares without progress. Progress being th measure of trial and stock price-which essentially hasn't moved in over year. It's biopharm, yeah, ok, when does people get held accountable?
i would be happy with ph3 transparency and some info on the longer range studies. Really any news to avoid this stock going to the gutter.